Cite
HARVARD Citation
Kurth, F. et al. (2023). Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial. Journal of global antimicrobial resistance. pp. 44-47. [Online].